Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Saline spray is an inert solution, typically consisting of sodium chloride in water, used as a placebo control in clinical trials. In the context of a Phase 4 randomized, double-blind, placebo-controlled trial conducted at the University of Pennsylvania (NCT01925469), it was utilized as a comparator to benzocaine spray to evaluate pain management during hysterosalpingogram (HSG). HSG is a radiographic procedure used to assess the uterine cavity and fallopian tubes in women undergoing infertility evaluation. As a placebo, saline spray lacks active pharmacological properties and serves to establish a baseline for efficacy and safety assessments. The study found no significant difference in pain relief between the benzocaine and saline spray groups during or after the procedure.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on saline spray.